Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
226,664,950
-
Total 13F shares
-
7,245,406
-
Share change
-
+4,660,487
-
Total reported value
-
$19,200,126
-
Put/Call ratio
-
78%
-
Price per share
-
$2.65
-
Number of holders
-
40
-
Value change
-
+$12,235,433
-
Number of buys
-
28
-
Number of sells
-
15
Institutional Holders of Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) as of Q1 2024
As of 31 Mar 2024,
Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,245,406 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, BlackRock Inc., GOLDMAN SACHS GROUP INC, MILLENNIUM MANAGEMENT LLC, CITIGROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, JANE STREET GROUP, LLC, and JPMORGAN CHASE & CO.
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.